Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01938040 · ClinicalTrials.gov registry record · Phase 4
Effect IV Ibuprofen and Inflammatory Responses
A Phase 4 study, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT01938040 is a Phase 4 study that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 60 participants.
The verdict
NCT01938040, a Phase 4 study, has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study is being done because the investigators wish to study ways to improve recovery after surgery. Injury, including surgical injury, causes inflammation. Inflammation is the body's attempt to protect itself and to start the healing process. Some surgical complications are related to the body's natural inflammatory response. Although mainly a healing response, inflammation can also have side effects which delay recovery. The investigators wish to determine the effect of a medication known as ibuprofen on recovery. You may know ibuprofen by the name Advil or Motrin. The medication will be given through the vein prior to the start of the surgery. Three blood samples will be taken, two while the patient is under anesthesia. The subject will be asked to complete several questionnaires.
Interventions
- DRUG ibuprofen
- OTHER sugar water/placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-05 |
| Est. Completion | 2014-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01938040
The ClinicalTrials.gov registry entry for NCT01938040 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ibuprofen is the first listed.
NCT01938040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01938040 about?
NCT01938040 is a clinical study titled "Effect IV Ibuprofen and Inflammatory Responses". This study is being done because the investigators wish to study ways to improve recovery after surgery. Injury, including surgical injury, causes inflammation. Inflammation is the body's attempt to protect itself and to start the healing process. Some surgical complications are related to the body'...
What is the current status of trial NCT01938040?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2013-05. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01938040?
The interventions under investigation include: ibuprofen (DRUG), sugar water/placebo (OTHER).
Who is sponsoring clinical trial NCT01938040?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.